Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 10-day trial to continue exploring with full access.

Bring me the head of Martin Shkreli

Bill Coffin | March 12, 2018

On March 9, former pharmaceutical executive Martin Shkreli was sentenced to seven years in prison for securities fraud, bringing to a close (at least, for now) the ongoing saga of America’s most hated man. Shkreli earned that title for himself in 2015 when, as the founder and CEO of Turing Pharmaceuticals, he obtained the manufacturing license for the generic anti-parasitic drug Daraprim—a drug of life-saving importance to those who need it, like AIDS patients—and then hiked the price by an astounding 5,000%, to $750 a dose. The move prompted so much public outrage that it even became a talking point in the 2016 presidential campaign, raising concerns that maybe pharmaceutical pricing needs to be regulated more closely to prevent another Daraprim scenario.... To get the full story, subscribe now.